首页> 外国专利> NOVEL T-CELL LYMPHOMA CDNA CLONES

NOVEL T-CELL LYMPHOMA CDNA CLONES

机译:新型T细胞淋巴瘤DNA克隆

摘要

The present invention provides novel DNA sequences, recombinant DNA (rDNA)molecules, processes for producingnovel T-cell proteins expressed in T-cell development, the novel T-cellproteins in substantially pure farm and antibodies whichbind to the novel proteins. More particularly, it relates to novel DNAsequences expressed in appropriate host and the novel T-cell proteins produced in these hosts. The present invention also providesnovel transmembrane proteins in substantially pureform, rDNA molecules encoding said transmembrane proteins and processes forproducing the novel transmembrane proteins.The DNA sequences and recombinant DNA molecules of this invention arecharacterized in that they are expressed by T lym-phoma cells and have at least one of the following characteristics: (1) isexpressed in normal thymus, activated spleen cells, ar gutassociated lymphoid tissue. (2) is expressed in ovarian tissue, normal liverand/or in a stage specific manner in embryonic devel-opment and (3) encode novel transmembrane proteins having multiple membranespanning domains.
机译:本发明提供了新颖的DNA序列,重组DNA(rDNA)分子,生产过程在T细胞发育中表达的新型T细胞蛋白,新型T细胞基本上纯净的农场中的蛋白质和抗体与新型蛋白质结合。更具体地说,它涉及新型DNA在适当宿主中表达的序列和新型T-这些宿主中产生的细胞蛋白。本发明还提供纯净的新型跨膜蛋白形式,编码所述跨膜蛋白的rDNA分子及其形成过程产生新型跨膜蛋白。本发明的DNA序列和重组DNA分子是特点是它们由T lym-phoma细胞,并至少具有以下特征之一:(1)是在正常胸腺,活化的脾细胞,肠中表达相关淋巴组织。 (2)在卵巢组织,正常肝脏中表达和/或以特定阶段的方式在胚胎发育中选项和(3)编码具有多个膜的新型跨膜蛋白跨域。

著录项

  • 公开/公告号CA2080018C

    专利类型

  • 公开/公告日2003-10-14

    原文格式PDF

  • 申请/专利权人 RESEARCH DEVELOPMENT FOUNDATION;

    申请/专利号CA19912080018

  • 发明设计人 MACLEOD CAROL L.;

    申请日1991-04-12

  • 分类号C12N15/12;A61K39/00;C12N1/21;C12N15/70;C07K14/725;

  • 国家 CA

  • 入库时间 2022-08-21 23:58:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号